Managed Account Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Managed Account Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.72M	Buy	13,827 +9,570	+225%	+$1.16M	﹤0.01%	1891
2015 Q1	$503K	Buy	+4,257	New	+$481K	﹤0.01%	2261

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

Managed Account Advisors's FBT Position: Q2 2015 in Review

Managed Account Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 225% in Q2 2015, buying an estimated $1.16M and bringing the position to 13,827 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Managed Account Advisors first reported a position in FBT in Q1 2015 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold FBT as of Q2 2015.

Managed Account Advisors held 13,827 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.72M as of Q2 2015.
Managed Account Advisors bought 9,570 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2015, an estimated $1.16M.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1891 holding.
Managed Account Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and has held it in 2 quarters since.
126 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.